The hazard of major and non-major clinically relevant bleeding increased with cTTR ( P for interaction = @ ) , however , the estimated reduction by rivaroxaban compared with warfarin in the hazard of intracranial hemorrhage was preserved across a wide range of threshold cTTR values .